000 | 01844 a2200565 4500 | ||
---|---|---|---|
005 | 20250515103717.0 | ||
264 | 0 | _c20080826 | |
008 | 200808s 0 0 eng d | ||
022 | _a1476-5551 | ||
024 | 7 |
_a10.1038/sj.leu.2405077 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStamatopoulos, K | |
245 | 0 | 0 |
_aLymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia. _h[electronic resource] |
260 |
_bLeukemia _cJul 2008 |
||
300 |
_a1446-9 p. _bdigital |
||
500 | _aPublication Type: Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 | _aAntibodies, Monoclonal, Murine-Derived |
650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 |
_aBone Marrow _xpathology |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHematopoiesis |
650 | 0 | 4 |
_aHematopoietic Stem Cells _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
650 | 0 | 4 |
_aLymphocyte Subsets _ximmunology |
650 | 0 | 4 |
_aLymphoma _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyelodysplastic Syndromes _xpathology |
650 | 0 | 4 |
_aNeutropenia _xchemically induced |
650 | 0 | 4 | _aRituximab |
700 | 1 | _aPapadaki, T | |
700 | 1 | _aPontikoglou, C | |
700 | 1 | _aAthanasiadou, I | |
700 | 1 | _aStavroyianni, N | |
700 | 1 | _aBux, J | |
700 | 1 | _aBatsis, I | |
700 | 1 | _aPyrovolaki, K | |
700 | 1 | _aPaterakis, G | |
700 | 1 | _aAnagnostou, D | |
700 | 1 | _aAnagnostopoulos, A | |
700 | 1 | _aPapadaki, H A | |
773 | 0 |
_tLeukemia _gvol. 22 _gno. 7 _gp. 1446-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2405077 _zAvailable from publisher's website |
999 |
_c17694984 _d17694984 |